Complement activation by propofol and its effect during propofol anaesthesia

Anaesthesia and Intensive Care

Volumn 27, Issue 6, 1999, Pages 623-627

  Ohmizo, H ^a   Iwama, H ^a   Sugita, T ^b  

^a Central Aizu General Hospital   (Japan)

^b OHU UNIVERSITY   (Japan)

Author keywords

Anaesthetics, intravenous: propofol, complement

Indexed keywords

ANESTHETIC AGENT; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4A; NAFAMSTAT MESILATE; PROPOFOL; SOLVENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLEMENT ACTIVATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; SUPERNATANT;

EID: 0033371642     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x9902700611     Document Type: Article

References (19)

1. Borgeat A, Popovic V, Nicole A, Schwander D. Acute pulmonary oedema following administration of ornithine-8-vasopressin. Br J Anaesth 1990; 65:548-551.
2. Soto J, Sacristan JA, Alsar MJ. Pulmonary oedema due to fentanyl? Anaesthesia 1992; 47:913-914.
3. Kitson GE, Wauchob TD. Pulmonary oedema following carbamazepine overdose. Anaesthesia 1988; 43:967-969.
4. Calder I, Ordman AJ, Jackowski S, Crockard HA. The Brain laryngeal mask airway. An alternative to emergency tracheal intubation. Anaesthesia 1990; 45:137-139.
5. Donnelly JA, Webster RE. Computer-controlled anaesthesia in the management of bronchopleural fistula. Anaesthesia 1991; 46:383-384.
6. Iwama H, Watanabe K, Kaneko T, Komatsu T. No lipid droplets in blood during propofol anaesthesia. Can J Anaesth 1996; 43:1081.
7. Erol U, Özgüven V, Celebioglu B, Aypar Ü. Propofol and humoral immunity. Turk Anesteziyol Reanim 1992; 20:261-264 (in Turkish with English abstract).
8. Jacob HS, Craddock PR, Hammerschmidt DE, Moldow CF. Complement-induced granulocyte aggregation: An unsuspected mechanism of disease. N Engl J Med 1980; 302:789-794.
9. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW. Complement activation during cardiopulmonary bypass: Evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 1981; 304:497-503.
10. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86:845-857.
11. Moat NE, Shore DF, Evans TW. Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins. Eur J Cardio-thorac Surg 1993; 7:563-571
12. Greer J. Comparative structural anatomy of the complement anaphylatoxin proteins C3a, C4a, and C5a. Enzyme 1986; 150:15-163.
13. Fujii S, Hitomi Y. New synthetic inhibitor of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin. Biochim Biophys Acta 1981; 661:342-345.
14. Hitomi Y, Ikari N, Fujii S. Inhibitory effects of a new synthetic protease inhibitor (FUT-175) on the coagulation system. Haemostasis 1985; 15:164-168.
15. Pâque EC, Römisch J. Comparative study on the in vitro effectiveness of antithrombotic agents. Thromb Res 1991; 64:11-21.
16. Okajima K, Uchiba M, Murakami K. Nafamostat mesilate. Cardiovasc Drug Rev 1995; 13:51-65.
17. Hagen C, Desborough JP, Kehlet H. Prolactin, LH, FSH, GH and cortisol response to surgery and the effect of epidural analgesia. Acta Endocrinol 1980; 94:151-154.
18. Moore CM, Desborough JP, Powell H, Burrin JM, Hall GM. Effects of extradural anaesthesia on interlcukin-6 and acute phase response to surgery. Br J Anaesth 1994; 72:272-279.
19. Schur PH. Complement studies of sera and other biologic fluids. Hum Pathol 1983; 14:338-342.